Taking stock of humanitarian access to pandemic vaccines

Discussion paper on key learnings from the COVAX humanitarian buffer experience.

Download

Humanitarian buffer transition

The nature of the challenge has shifted since the Buffer was first designed: COVID-19 vaccine supply is no longer constrained, global demand has slowed, countries and humanitarian contexts in particular are dealing with multiple competing priorities. With the main need now funding and supporting effective delivery of available doses to vulnerable groups, partners will work through existing programmes and platforms, leveraging available COVID-19 delivery funding, to integrate the delivery of COVID-19 vaccines with other critical services in humanitarian contexts.

• Pillar 1: Closing the application window to support the shift away from top-down supply to effective delivery and integration into routine services, the Buffer will no longer accept applications after 31 December 2022.
• Pillar 2: Supporting delivery and integration with routine services COVAX Partners will work to provide coordinated support and resources for delivering COVID-19 vaccines in humanitarian settings, integrated into existing channels within each organization, for implementation by government and CSOs. This effort will be complementary to global and local efforts to integrate COVID-19 vaccination with routine programs.
• Pillar 3: Documenting and actioning lessons learned COVAX’s work in humanitarian settings and the Humanitarian Buffer have generated critical learnings on addressing systemic roadblocks during an unprecedented global crisis. Partners are committed to a deeper dive into challenges to ensure improvements are made in the face of increasingly inevitable future pandemics.

Challenges & learning agenda

A key takeaway from the Buffer is that access during a pandemic, in settings where governments play an active role and can access groups, is feasible despite political and other complexities. However, many global health unilateral and multilateral actors have long faced difficulties operating in humanitarian settings. These challenges were exacerbated working with non-governmental actors to import and deliver novel products in a pandemic environment, particularly outside state-based architecture, proved incredibly challenging due to a range of systemic, legal and regulatory factors.

To date, the COVAX Humanitarian Buffer has received nine applications, of which six were approved; of which three were withdrawn, one is on hold indefinitely, and two have been fulfilled.

Initial learnings and recommendations, such as contingency waivers for humanitarian import during a pandemic, are outlined in a Gavi Discussion Paper and in the COVAX: Key Learnings for Future Pandemic Preparedness and Response white paper published by COVAX partners. Partners will work together on further knowledge products and collaborate on a plan of action for future pandemics.

COVAX Humanitarian Buffer Application: CLOSED

As of 31 December 2022, The COVAX Humanitarian Buffer is no longer accepting new applications. COVAX partners are working through existing programmes and platforms, leveraging available COVID-19 delivery funding, to integrate the delivery of COVID-19 vaccines with other services in humanitarian contexts. ​ 

*Participants will be required to complete and submit the Humanitarian Buffer Standard Reporting Form to Gavi. This reporting form must be completed and submitted within three months after the completion of the programme activities, or within nine months after the doses were received by the Participant, whichever date is earlier.